Do trans fats causally increase cardiovascular disease risk?

Why this question matters

The claim is that dietary trans fats, especially industrially produced partially hydrogenated oils, increase the risk of cardiovascular disease through causal biological and population-level pathways. The preliminary assessment is that this relationship is well supported, while some distinctions remain between industrial and naturally occurring trans fats and between different intake levels.

The claim being judged

The claim asks whether trans fats causally increase cardiovascular disease, not merely whether trans fat intake is correlated with less healthy dietary patterns. Cardiovascular disease includes outcomes such as coronary heart disease, myocardial infarction, stroke, and cardiovascular mortality, though much of the strongest evidence has focused on coronary heart disease.

Trans fats are unsaturated fatty acids with at least one double bond in the trans configuration. The public health concern has centered on industrial trans fats, especially those produced by partial hydrogenation of vegetable oils and historically used in some margarines, shortenings, baked goods, fried foods, and packaged foods.

Small amounts of trans fats also occur naturally in ruminant-derived foods such as dairy and beef. The causal question is therefore best framed with attention to dose and source: whether increasing dietary trans fat intake, particularly from industrial sources, increases cardiovascular risk compared with otherwise similar diets lower in trans fats.

What the evidence shows

Controlled feeding studies indicate that replacing cis unsaturated fats or carbohydrates with trans fats tends to worsen established cardiovascular risk markers. Reported effects include higher LDL cholesterol, lower HDL cholesterol in some comparisons, a less favorable total-to-HDL cholesterol ratio, and possible effects on lipoprotein(a), inflammatory markers, and endothelial function.

Prospective cohort studies have generally found that people with higher trans fat intake have higher rates of coronary heart disease, even after statistical adjustment for other dietary and lifestyle factors. Observational evidence cannot remove all potential confounding, but the direction of association, dose-response patterns, and consistency with lipid effects are important for causal assessment.

Policy and natural-experiment evidence also contributes. Jurisdictions that restricted industrial trans fats or removed partially hydrogenated oils from the food supply observed reductions in trans fat exposure, and some studies reported favorable changes in cardiovascular outcomes after implementation. These studies are not perfectly isolated experiments because other health trends can occur at the same time, but they are relevant because they examine population-level exposure changes.

Major public health bodies have concluded that industrial trans fat intake should be minimized or eliminated from the food supply. The overall causal case is strengthened by convergence across randomized biomarker studies, long-term epidemiology, mechanistic plausibility, and observed effects of regulatory changes.

Where uncertainty remains

The largest remaining nuance concerns source and amount. Industrial trans fats at historically common intake levels have the clearest connection to cardiovascular risk. Naturally occurring ruminant trans fats are typically consumed at lower levels, and the available evidence is less uniform for those exposures.

Another uncertainty is the precise size of the effect in today’s food environments, where many countries have already reduced or banned partially hydrogenated oils. Current risk depends on actual exposure, labeling rules, food supply compliance, and whether trans fats are replaced with healthier unsaturated fats or with other less favorable ingredients.

For individual risk, trans fat intake is one contributor among many, including smoking, blood pressure, LDL cholesterol, diabetes, physical activity, overall dietary pattern, and genetics. The causal assessment of trans fats does not imply that trans fats are the only or dominant driver of cardiovascular disease in every person or population.

The three parts of the claim

The umbrella claim is actually several claims bundled into one. Each needs its own evaluation.

Common questions